{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:59:40Z","timestamp":1778173180224,"version":"3.51.4"},"reference-count":47,"publisher":"Informa UK Limited","issue":"2","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Universidad Tecnol\u00f3gicade Pereira","award":["ID PER00095"],"award-info":[{"award-number":["ID PER00095"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1080\/21645515.2023.2257424","type":"journal-article","created":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T21:27:59Z","timestamp":1695072479000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["High coverage and timeliness of vaccination of children under 6 years of age in Risaralda, Colombia"],"prefix":"10.1080","volume":"19","author":[{"given":"Jorge Enrique","family":"Machado-Alba","sequence":"first","affiliation":[{"name":"Universidad Tecnol\u00f3gica de Pereira-Audifarma SA","place":["Pereira, Colombia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel Enrique","family":"Machado-Duque","sequence":"additional","affiliation":[{"name":"Universidad Tecnol\u00f3gica de Pereira-Audifarma SA","place":["Pereira, Colombia"]},{"name":"Fundaci\u00f3n Universitaria Aut\u00f3noma de las Am\u00e9ricas","place":["Pereira, Colombia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan C.","family":"Vargas-Zambrano","sequence":"additional","affiliation":[{"name":"Sanofi","place":["Lyon, France"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,9,18]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1805990"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1370\/afm.2017"},{"key":"e_1_3_6_4_1","first-page":"352","article-title":"Centers for disease control and prevention (CDC). Benefits from immunization during the vaccines for children program era - United States, 1994\u20132013","volume":"63","author":"Whitney CG","year":"2014","unstructured":"Whitney CG, Zhou F, Singleton J, Schuchat A. Centers for disease control and prevention (CDC). Benefits from immunization during the vaccines for children program era - United States, 1994\u20132013. MMWR Morb Mortal Wkly Rep. 2014;63:352\u20135.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e328352f727"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365548.2011.582247"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1616503"},{"key":"e_1_3_6_8_1","unstructured":"Ministerio de Salud de Colombia - Plan de Respuesta del sector salud al fen\u00f3meno migratorio. Bogot\u00e1 (DC) Colombia; 2018 [accessed 2022 Feb 1]. https:\/\/www.minsalud.gov.co\/sites\/rid\/Lists\/BibliotecaDigital\/RIDE\/DE\/COM\/plan-respuesta-salud-migrantes.pdf."},{"key":"e_1_3_6_9_1","unstructured":"Perfil Migratorio de Colombia 2021. International organization for migration. UN Migration. PUB2022\/127\/R. 2022 [accessed 2023 Jul 31]. https:\/\/publications.iom.int\/books\/perfil-migratorio-de-colombia-2021."},{"key":"e_1_3_6_10_1","unstructured":"Gobernaci\u00f3n de Risaralda. En Risaralda hay m\u00e1s de 33 mil migrantes venezolanos con el Permiso por Protecci\u00f3n temporal. Colombia; 2022 [accessed 2023 Jul 31]. https:\/\/www.risaralda.gov.co\/publicaciones\/157302\/en-risaralda-hay-mas-de-33-mil-migrantes-venezolanos-con-el-permiso-por-proteccion-temporal\/#:~:text=Seg%C3%BAn%20informaci%C3%B3n%20de%20Migraci%C3%B3n%20Colombia que%20garantizan%20los%20derechos%20de."},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2015.06.009"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.01.081"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/1468-0009.12417"},{"key":"e_1_3_6_14_1","unstructured":"World Health Organization. Immunization schedules. [accessed 2023 Apr 18]. https:\/\/www.who.int\/immunization\/policy\/schedules\/en\/."},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.acap.2022.08.003"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1409318"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.01.073"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2007.06.010"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0124-00642009000200008"},{"key":"e_1_3_6_20_1","unstructured":"Ministerio de la Protecci\u00f3n Social. Lineamiento para la evaluaci\u00f3n de coberturas oportunidad y esquema completo de vacunaci\u00f3n. Bogot\u00e1 Colombia; 2011 [accessed 2022 Feb 1]. https:\/\/www.minsalud.gov.co\/Lineamientos\/Lineamiento%20para%20la%20evaluaci%C3%B3n%20de%20coberturas.pdf."},{"key":"e_1_3_6_21_1","first-page":"72","article-title":"Patterns of pharmacologic and non-pharmacologic treatment, treatment satisfaction and perceived tolerability in patients with fibromyalgia: a patients\u2019 survey","volume":"38","author":"Rico-Villademoros F","year":"2020","unstructured":"Rico-Villademoros F, Postigo-Martin P, Garcia-Leiva JM, Ordo\u00f1ez-Carrasco JL, Calandre EP. Patterns of pharmacologic and non-pharmacologic treatment, treatment satisfaction and perceived tolerability in patients with fibromyalgia: a patients\u2019 survey. Clin Exp Rheumatol. 2020;38:72\u20138.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_6_22_1","unstructured":"DANE. Resultados Censo Nacional de Poblaci\u00f3n y Vivienda 2018. Pereira Risaralda; 2019 [accessed 2022 Feb 1]. https:\/\/www.dane.gov.co\/files\/censo2018\/informacion-tecnica\/presentaciones-territorio\/190731-CNPV-presentacion-Risaralda-Pereira.pdf."},{"key":"e_1_3_6_23_1","first-page":"220","article-title":"Evaluaci\u00f3n del impacto de la vacuna contra rotavirus en Colombia usando m\u00e9todos r\u00e1pidos de evaluaci\u00f3n [Impact assessment of the rotavirus vaccine in Colombia using rapid evaluation methods]","volume":"34","author":"Cotes K","year":"2013","unstructured":"Cotes K, Alvis-Guzm\u00e1n N, Rico A, Porras A, Cediel N, Chocont\u00e1 Piraquive LA, De la Hoz F. Evaluaci\u00f3n del impacto de la vacuna contra rotavirus en Colombia usando m\u00e9todos r\u00e1pidos de evaluaci\u00f3n [Impact assessment of the rotavirus vaccine in Colombia using rapid evaluation methods]. Rev Panam Salud Publica. 2013;34:220\u20136.","journal-title":"Rev Panam Salud Publica"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-021-11345-z"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2020.10.002"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12939-014-0118-y"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.10.1204"},{"key":"e_1_3_6_28_1","unstructured":"Rinc\u00f3n Villamizar HI Escobar Ortiz JL. IDH y PIB en Colombia: un an\u00e1lisis de convergencia departamental. 2019 [accessed 2022 Feb 1]. chrome-extension:\/\/efaidnbmnnnibpcajpcglclefindmkaj\/https:\/\/repository.ucatolica.edu.co\/bitstream\/10983\/23858\/1\/IDH%20y%20PIB%20en%20Colombia%2C%20un%20an%C3%A1lisis%20de%20convergencia%20departamental.pdf."},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.32468\/dtseru.222"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.02.093"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1157239"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.19118"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.04.048"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.7196\/SAMJ.2019.v109i8.13244"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1057\/s41271-020-00255-w"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.06.030"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.26633\/RPSP.2020.56"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.03.079"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-0698"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.67635"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6920e1"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(20)30308-9"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.08.019"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.04.023"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.26633\/RPSP.2017.123"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.acap.2021.07.003"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-018-5103-8"},{"key":"e_1_3_6_48_1","unstructured":"Instituto Nacional de Salud. Informe Quincenal Epidemiol\u00f3gico Nacional (IQEN). INFORME DE EVENTO Colombia 2019 Bogot\u00e1 Colombia. 2019 [accessed 2022 Feb 1]. https:\/\/www.ins.gov.co\/buscador-eventos\/Paginas\/IQEN.aspx."}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2023.2257424","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:55:41Z","timestamp":1770818141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2023.2257424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["10.1080\/21645515.2023.2257424"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2023.2257424","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-06-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2257424"}}